Partial nephrectomy for renal cell carcinoma in long-term renal allografts: operative and post-operative considerations.

Ashley Cox, Christopher Y. Nguan, Patrick P.W. Luke

Research output: Contribution to journalArticlepeer-review

11 Citations (Scopus)

Abstract

The majority of immunosuppressive agents used to prevent rejection in transplant patients have also been shown to increase malignancy risk. Renal transplant patients are dependent upon their solitary allograft kidney in order to remain dialysis free, and the discovery of a primary malignancy within the allograft poses a therapeutic dilemma. We describe two cases of primary renal allograft malignancies and discuss nephron-preserving surgical treatment. Furthermore, we discuss the potential anti-tumor role of the immunosuppressive agent sirolimus in the treatment of these complex patients.

Original languageEnglish
Pages (from-to)2887-2890
Number of pages4
JournalCanadian Journal of Urology
Volume12
Issue number6
Publication statusPublished - Dec 2005
Externally publishedYes

ASJC Scopus Subject Areas

  • Urology

Fingerprint

Dive into the research topics of 'Partial nephrectomy for renal cell carcinoma in long-term renal allografts: operative and post-operative considerations.'. Together they form a unique fingerprint.

Cite this